Entrada Therapeutics (TRDA) Cash from Financing Activities (2020 - 2026)
Entrada Therapeutics (TRDA) posted Cash from Financing Activities of $350,000 for Q2 2026, up 3.9% from $337,000 a year earlier and up 250.0% from the prior quarter.
Powered by 
Analysis
Entrada Therapeutics (TRDA) Cash from Financing Activities (2020 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Cash from Financing Activities at Entrada Therapeutics was $650,000, down 68.7% year-over-year; for FY2025, it came in at $887,000, down 99.1% from FY2024.
- Annual Cash from Financing Activities shows a five-year compound annual growth rate of -55.4% (FY2020 to FY2025).
- In prior years, Entrada Therapeutics' Cash from Financing Activities was $102.96 million in FY2024 (+389.4%), $21.04 million in FY2023, $479,000 in FY2022 (-99.8%) and $307.46 million in FY2021 (+513.8%).
- Quarterly Cash from Financing Activities has run from a low of -$11,000 in Q3 2024 to a high of $190.76 million in Q4 2021 over five years.
- On a year-over-year basis, Cash from Financing Activities increased in three of the last six quarters, with an average decline of 13.4%.
- The strongest year-over-year quarter for Cash from Financing Activities in the past five years was Q3 2023, with growth of 513.3%; the weakest was Q1 2022, with a decline of 100.0%.
- According to Business Quant data, Cash from Financing Activities for the three prior quarters was $100,000 (Q1 2026), $192,000 (Q4 2025) and $8,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | -426.70 Mn |
| 10 | Entrada Therapeutics | 247.25 Mn | 247.25 Mn | - | 350,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 350,000.00 |
| Mar 31, 2026 | 100,000.00 |
| Dec 31, 2025 | 192,000.00 |
| Sep 30, 2025 | 8,000.00 |
| Jun 30, 2025 | 337,000.00 |
| Mar 31, 2025 | 350,000.00 |
| Dec 31, 2024 | 1.40 Mn |
| Sep 30, 2024 | -11,000.00 |
| Jun 30, 2024 | 101.37 Mn |
| Mar 31, 2024 | 206,000.00 |
| Dec 31, 2023 | 690,000.00 |
| Sep 30, 2023 | 368,000.00 |
| Jun 30, 2023 | 443,000.00 |
| Mar 31, 2023 | 19.54 Mn |
| Dec 31, 2022 | 358,000.00 |
| Sep 30, 2022 | 60,000.00 |
| Jun 30, 2022 | 11,000.00 |
| Mar 31, 2022 | 50,000.00 |
| Dec 31, 2021 | 190.76 Mn |
| Sep 30, 2021 | 106,000.00 |
API Access
Entrada Therapeutics Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=TRDA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "TRDA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=TRDA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();